E. Maymon et al., ISOLATED HYDRAMNIOS AT TERM GESTATION AND THE OCCURRENCE OF PERIPARTUM COMPLICATIONS, European journal of obstetrics, gynecology, and reproductive biology, 77(2), 1998, pp. 157-161
Objective: To determine if hydramnios at term gestation is an independ
ent risk factor for poor pregnancy outcome and perinatal death. Study
design: The study population consisted of 60 702 patients with singlet
on gestation who delivered at term (>37 weeks). Patients were classifi
ed into two groups according to the presence or the absence of hydramn
ios. Hydramnios was diagnosed in the presence of an amniotic fluid ind
ex greater than 25 cm or of a maximum vertical pocket of amniotic flui
d of at least 8 cm or by subjective assessment. Logistic regression an
alysis was used to evaluate the unique contribution of hydramnios to f
etal death and to perinatal and maternal morbidity. Results: The preva
lence of hydramnios was 1211/60 702 (2%). Patients with hydramnios had
a higher incidence of complications than those with a normal amount o
f amniotic fluid: cesarean section (22.8 vs. 8.5%, P<0.01), antepartum
death (0.6 vs. 0.2%, P<0.005), postpartum death (2.8 vs. 0.4%, P<0.01
), abruptio placenta (0.9 vs. 0.3%, P<0.001), fetal distress (6.1 vs.
3.65%, P<0.0015), meconium-stained amniotic fluid (17.8 vs. 15%, P<0.0
01), low Apgar score at 5 min (2.95 vs. 1%, P<0.01), malpresentation (
6.8 vs. 2.9%, P<0.01), clinical chorioamnionitis (0.3 vs. 0.1%, P<0.05
), prolapse of cord (2.2 vs. 0.3%, P<0.01), and large-for-gestational-
age infant (LGA) (23.8 vs. 8.1%, P<0.01). When adjusted for confoundin
g variables, the presence of hydramnios remained strongly associated w
ith perinatal mortality (odds ratio 5.5 (95% CI 3.2-9.3)) and neonatal
and maternal morbidity (odds ratios 2.1 (CI 1.1-3.7) and 2.3 (CI 1.9-
2.7), respectively). Conclusions: (1) Hydramnios at term is an indepen
dent risk factor for perinatal death; (2) Fetal surveillance is warran
ted in patients with hydramnios even in the absence of other known ris
k factors for adverse pregnancy outcome. (C) 1998 Elsevier Science Ire
land Ltd.